Treatment duration for Lyme disease summary and conclusions

1. Better research, consisting of properly designed and well conducted studies measuring both benefits and risks, is needed to determine the optimal duration of antibiotic treatment for Lyme borreliosis. There is currently insufficient evidence to determine whether extending antibiotic treatment bey...

Full description

Bibliographic Details
Corporate Author: Statens beredning för medicinsk utvärdering (Sweden)
Format: eBook
Language:English
Published: Stockholm Swedish Council on Health Technology Assessment (SBU) 2013, December 2013
Series:SBU alert report
Subjects:
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
Description
Summary:1. Better research, consisting of properly designed and well conducted studies measuring both benefits and risks, is needed to determine the optimal duration of antibiotic treatment for Lyme borreliosis. There is currently insufficient evidence to determine whether extending antibiotic treatment beyond 10 to 14 days improves health outcomes for patients with erythema migrans.2. There is insufficient evidence to determine if extended antibiotic treatment has any significant effect on neuroborreliosis, Lyme arthritis or other persistent symptoms of Lyme borreliosis.3. The extended treatment (>21 days) with antibiotics (ceftriaxone) via peripherally inserted central catheter, is associated with a not-insignificant risk of serious and potentially life-threatening complications
Physical Description:1 PDF file (2 pages)